News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,123 Results
Type
Article (42425)
Company Profile (307)
Press Release (694374)
Multimedia
Podcasts (88)
Webinars (20)
Section
Business (207549)
Career Advice (2068)
Deals (35888)
Drug Delivery (125)
Drug Development (82397)
Employer Resources (175)
FDA (16530)
Job Trends (15148)
News (350854)
Policy (33068)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2617)
Accelerated approval (42)
Adcomms (25)
Allergies (165)
Alliances (50481)
ALS (196)
Alzheimer's disease (1756)
Antibody-drug conjugate (ADC) (369)
Approvals (16846)
Artificial intelligence (605)
Autoimmune disease (227)
Automation (50)
Bankruptcy (366)
Best Places to Work (11709)
BIOSECURE Act (21)
Biosimilars (204)
Biotechnology (209)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (688)
Cancer (5352)
Cardiovascular disease (444)
Career advice (1754)
Career pathing (39)
CAR-T (304)
CDC (53)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (41)
Clinical research (70968)
Collaboration (1928)
Company closure (4)
Compensation (1281)
Complete response letters (70)
COVID-19 (2767)
CRISPR (102)
C-suite (998)
Cystic fibrosis (149)
Data (7112)
Decentralized trials (3)
Denatured (26)
Depression (159)
Dermatology (57)
Diabetes (553)
Diagnostics (6866)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (299)
Drug pricing (197)
Drug shortages (29)
Duchenne muscular dystrophy (266)
Earnings (91615)
Editorial (62)
Employer branding (21)
Employer resources (154)
Events (121376)
Executive appointments (1049)
FDA (19967)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1642)
Gene editing (216)
Generative AI (54)
Gene therapy (671)
GLP-1 (1029)
Government (4726)
Grass and pollen (6)
Guidances (396)
Healthcare (19021)
HIV (74)
Huntington's disease (53)
IgA nephropathy (91)
Immunology and inflammation (272)
Immuno-oncology (83)
Indications (158)
Infectious disease (3081)
Inflammatory bowel disease (205)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (277)
Interviews (322)
IPO (16769)
IRA (50)
Job creations (3761)
Job search strategy (1462)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (559)
Leadership (35)
Legal (8030)
Liver cancer (98)
Longevity (29)
Lung cancer (718)
Lymphoma (409)
Machine learning (53)
Management (59)
Manufacturing (932)
MASH (176)
Medical device (13870)
Medtech (13947)
Mergers & acquisitions (20281)
Metabolic disorders (1422)
mRNA (176)
Multiple sclerosis (173)
NASH (17)
Neurodegenerative disease (385)
Neuropsychiatric disorders (98)
Neuroscience (3160)
Neurotech (1)
NextGen: Class of 2026 (6598)
Non-profit (4555)
Now hiring (73)
Obesity (672)
Opinion (286)
Ovarian cancer (185)
Pain (227)
Pancreatic cancer (259)
Parkinson's disease (341)
Partnered (33)
Patents (557)
Patient recruitment (594)
Peanut (62)
People (60335)
Pharmaceutical (63)
Pharmacy benefit managers (32)
Phase 1 (22199)
Phase 2 (31290)
Phase 3 (23165)
Pipeline (7128)
Policy (304)
Postmarket research (2573)
Preclinical (9432)
Press Release (71)
Prostate cancer (276)
Psychedelics (50)
Radiopharmaceuticals (304)
Rare diseases (1001)
Real estate (6125)
Recruiting (72)
Regulatory (25200)
Reports (54)
Research institute (2442)
Resumes & cover letters (358)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (164)
Series A (276)
Series B (208)
Service/supplier (11)
Sickle cell disease (110)
Special edition (23)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3735)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (87)
The Weekly (60)
Vaccines (1067)
Venture capital (101)
Weight loss (428)
Women's health (109)
Worklife (19)
Date
Last 7 days (641)
Last 30 days (2551)
Last 365 days (30303)
2026 (8076)
2025 (30614)
2024 (35662)
2023 (40475)
2022 (51653)
2021 (56150)
2020 (54498)
2019 (46912)
2018 (35349)
2017 (32525)
2016 (32053)
2015 (38036)
2014 (31812)
2013 (26850)
2012 (29163)
2011 (29835)
2010 (27936)
Location
Africa (768)
Alabama (90)
Alaska (7)
Arizona (334)
Arkansas (14)
Asia (40436)
Australia (6740)
California (12379)
Canada (3516)
China (1246)
Colorado (526)
Connecticut (527)
Delaware (368)
Europe (88050)
Florida (1850)
Georgia (397)
Hawaii (3)
Idaho (62)
Illinois (982)
India (80)
Indiana (561)
Iowa (23)
Japan (489)
Kansas (133)
Kentucky (45)
Louisiana (38)
Maine (73)
Maryland (1488)
Massachusetts (8882)
Michigan (348)
Minnesota (678)
Mississippi (6)
Missouri (138)
Montana (36)
Nebraska (29)
Nevada (135)
New Hampshire (83)
New Jersey (3297)
New Mexico (29)
New York (3268)
North Carolina (1589)
North Dakota (9)
Northern California (6129)
Ohio (366)
Oklahoma (22)
Oregon (41)
Pennsylvania (2502)
Puerto Rico (26)
Rhode Island (50)
South America (1152)
South Carolina (76)
South Dakota (1)
Southern California (4853)
Tennessee (199)
Texas (1942)
United States (43883)
Utah (374)
Vermont (1)
Virginia (294)
Washington D.C. (80)
Washington State (1002)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
737,123 Results for "goodwin biotechnology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
September 17, 2025
·
4 min read
Psychedelics
Compass’ Psychedelic Shows Durability ‘In Spades’ as Path to FDA Clears
Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical Officer Guy Goodwin. By providing 26 weeks’ worth of such data instead of the requested 12, the company is delivering “in spades,” he said.
February 17, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development - February 10, 2026
February 11, 2026
·
3 min read
Press Releases
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
December 19, 2025
·
5 min read
Press Releases
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
March 9, 2026
·
9 min read
Press Releases
genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration
August 21, 2025
·
3 min read
Press Releases
Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer
March 31, 2026
·
3 min read
Press Releases
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
March 24, 2026
·
1 min read
Press Releases
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
February 24, 2026
·
5 min read
Press Releases
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 23, 2025
·
3 min read
1 of 73,713
Next
